217 related articles for article (PubMed ID: 30659197)
1. Cross-lineage protection by human antibodies binding the influenza B hemagglutinin.
Liu Y; Tan HX; Koutsakos M; Jegaskanda S; Esterbauer R; Tilmanis D; Aban M; Kedzierska K; Hurt AC; Kent SJ; Wheatley AK
Nat Commun; 2019 Jan; 10(1):324. PubMed ID: 30659197
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.
de Vries RD; Nieuwkoop NJ; Krammer F; Hu B; Rimmelzwaan GF
Virus Res; 2020 Feb; 277():197839. PubMed ID: 31837382
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
[TBL] [Abstract][Full Text] [Related]
4. Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.
de Vries RD; Nieuwkoop NJ; van der Klis FRM; Koopmans MPG; Krammer F; Rimmelzwaan GF
J Infect Dis; 2017 Dec; 217(1):3-11. PubMed ID: 29294018
[TBL] [Abstract][Full Text] [Related]
5. Development of an Alternative Modified Live Influenza B Virus Vaccine.
Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
[TBL] [Abstract][Full Text] [Related]
6. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
[TBL] [Abstract][Full Text] [Related]
7. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
[TBL] [Abstract][Full Text] [Related]
8. Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice.
Fang F; Cai XQ; Chang HY; Wang HD; Yang ZD; Chen Z
Acta Virol; 2008; 52(2):107-12. PubMed ID: 18564897
[TBL] [Abstract][Full Text] [Related]
9. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
Shen C; Chen J; Li R; Zhang M; Wang G; Stegalkina S; Zhang L; Chen J; Cao J; Bi X; Anderson SF; Alefantis T; Zhang M; Cai X; Yang K; Zheng Q; Fang M; Yu H; Luo W; Zheng Z; Yuan Q; Zhang J; Wai-Kuo Shih J; Kleanthous H; Chen H; Chen Y; Xia N
Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046433
[TBL] [Abstract][Full Text] [Related]
10. A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection.
Zeng D; Xin J; Yang K; Guo S; Wang Q; Gao Y; Chen H; Ge J; Lu Z; Zhang L; Chen J; Chen Y; Xia N
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746776
[TBL] [Abstract][Full Text] [Related]
11. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
Verma S; Soto J; Vasudevan A; Schmeisser F; Alvarado-Facundo E; Wang W; Weiss CD; Weir JP
PLoS One; 2017; 12(4):e0175733. PubMed ID: 28423025
[TBL] [Abstract][Full Text] [Related]
12. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
[TBL] [Abstract][Full Text] [Related]
13. A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages.
Carlock MA; Ross TM
Sci Rep; 2023 Sep; 13(1):15911. PubMed ID: 37741893
[TBL] [Abstract][Full Text] [Related]
14. Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.
Vigil A; Estélles A; Kauvar LM; Johnson SK; Tripp RA; Wittekind M
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507069
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibodies to hemagglutinin of influenza b viruses victoria evolutionary lineage.].
Sorokin EV; Tsareva TR; Zheltukhina AI
Vopr Virusol; 2018; 63(6):275-280. PubMed ID: 30641023
[TBL] [Abstract][Full Text] [Related]
16. Highly conserved protective epitopes on influenza B viruses.
Dreyfus C; Laursen NS; Kwaks T; Zuijdgeest D; Khayat R; Ekiert DC; Lee JH; Metlagel Z; Bujny MV; Jongeneelen M; van der Vlugt R; Lamrani M; Korse HJ; Geelen E; Sahin Ö; Sieuwerts M; Brakenhoff JP; Vogels R; Li OT; Poon LL; Peiris M; Koudstaal W; Ward AB; Wilson IA; Goudsmit J; Friesen RH
Science; 2012 Sep; 337(6100):1343-8. PubMed ID: 22878502
[TBL] [Abstract][Full Text] [Related]
17. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
Schmeisser F; Vasudevan A; Verma S; Wang W; Alvarado E; Weiss C; Atukorale V; Meseda C; Weir JP
PLoS One; 2015; 10(1):e0117108. PubMed ID: 25629172
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies broadly neutralizing against influenza B virus.
Yasugi M; Kubota-Koketsu R; Yamashita A; Kawashita N; Du A; Sasaki T; Nishimura M; Misaki R; Kuhara M; Boonsathorn N; Fujiyama K; Okuno Y; Nakaya T; Ikuta K
PLoS Pathog; 2013 Feb; 9(2):e1003150. PubMed ID: 23408886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]